Pharmaceutical group · United States
Norwich
A group of 4 companies with 7 medicines in 2 countries.
Group structure
4 companies in 2 countries
United States1
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADALAT CC30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended release | Nifedipine | United States | Not marketed | 1993 |
| RIFAXIMIN200mg | 550mg · Tablet | Rifaximin | United States | Marketed | 2024 |
| DANTRIUM CAP 100MG100 mg · Capsule | Dantrolene | Canada | Cancelled | 1979 |
| DANTRIUM CAP 25MG25 mg · Capsule | Dantrolene | Canada | Cancelled | 1979 |
| MACRODANTIN CAP 100MG100 mg / cap · Capsule | Nitrofurantoin | Canada | Cancelled | 1979 |
| MACRODANTIN CAP 25MG25 mg / cap · Capsule | Nitrofurantoin | Canada | Cancelled | 1979 |
| MACRODANTIN CAP 50MG50 mg / cap · Capsule | Nitrofurantoin | Canada | Cancelled | 1979 |